200 Results
Guidelines and Advice
Status: Current
ID: Guideline Endorsement C50-CIDAP-2
ID: Guideline Endorsement C50-CIDAP-2
Nov 2024
Drug
Nov 2024
Guidelines and Advice
Status: Current
Version: 1
Version: 1
Nov 2024
Drug
Other Name(s): Avastin®
, Mvasi®; Zirabev®; Bambevi®; Abevmy®; Aybintio®; Vegzelma™
Nov 2024
Drug
Nov 2024
Guidelines and Advice
Status: In-Review
ID: RR SCT-9
Version: N/A
ID: RR SCT-9
Version: N/A
Jun 2020
Statistical Reports
Aug 2020
Statistical Reports